Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  875 results for ""LACTAMS""

Your Filters

Publisher : wiley
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Application of 2-Azabicyclo[2.2.1]Hept-5-En-3-One (Vince Lactam) in Synthetic Organic and Medicinal Chemistry.

  • Authors : Nonn M; MTA TTK Lendület Artificial Transporter Research Group, Institute of Materials and Environmental Chemistry, HUN-REN Research Center for Natural Sciences, H-1117, Budapest, Magyar tudósok krt. 2, Hungary.; Fustero S

Subjects: Lactams*/Lactams*/Lactams*/chemistry ; Lactams*/Lactams*/Lactams*/chemical synthesis ; Lactams*/Lactams*/Lactams*/pharmacology

  • Source: Chemical record (New York, N.Y.) [Chem Rec] 2024 Sep; Vol. 24 (9), pp. e202400070. Date of Electronic Publication: 2024 Jul 15.Publisher: Wiley Country of Publication: United States NLM ID: 101085550 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A case study on severe psychiatric symptoms induced by lorlatinib.

  • Authors : Liu MA; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA.; Xu E

Subjects: Lactams* ; Lung Neoplasms*; Humans

  • Source: Psycho-oncology [Psychooncology] 2024 Jan; Vol. 33 (1), pp. e6283.Publisher: Wiley Country of Publication: England NLM ID: 9214524 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Patient Centric Microsampling to Support Paxlovid Clinical Development: Bridging and Implementation.

Subjects: Lactams* ; Ritonavir*; United States

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jan; Vol. 115 (1), pp. 42-51. Date of Electronic Publication: 2023 Sep 05.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Real-Life Comparison of Antivirals for SARS-CoV-2 Omicron Infection in Patients With Hematologic Malignancies.

  • Authors : Aiello TF; Infectious Diseases Department, Hospital Clinic of Barcelona-IDIBAPS, Universitat de Barcelona, Barcelona, Spain.; Peyrony O

Subjects: COVID-19* ; Hematologic Neoplasms* ; Lactams* SARS-CoV-2 variants

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024; Vol. 18 (3), pp. e13264.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Lorlatinib Exposure-Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit-Risk Assessment in Non-Small Cell Lung Cancer.

Subjects: Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/diagnosis ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/metabolism; Aminopyridines/Aminopyridines/Aminopyridines/*adverse effects

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Nov; Vol. 110 (5), pp. 1273-1281. Date of Electronic Publication: 2021 Jun 26.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.

Subjects: Arthritis, Experimental/Arthritis, Experimental/Arthritis, Experimental/*drug therapy ; Interleukin-1 Receptor-Associated Kinases/Interleukin-1 Receptor-Associated Kinases/Interleukin-1 Receptor-Associated Kinases/*antagonists & inhibitors ; Isoquinolines/Isoquinolines/Isoquinolines/*therapeutic use

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2021 Dec; Vol. 73 (12), pp. 2206-2218. Date of Electronic Publication: 2021 Nov 01.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Cutaneous sarcoid-like drug reaction caused by an anaplastic lymphoma kinase inhibitor.

  • Authors : Gleue CA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.; Shah K

Subjects: Adenocarcinoma of Lung/Adenocarcinoma of Lung/Adenocarcinoma of Lung/*drug therapy ; Aminopyridines/Aminopyridines/Aminopyridines/*adverse effects ; Anaplastic Lymphoma Kinase/Anaplastic Lymphoma Kinase/Anaplastic Lymphoma Kinase/*antagonists & inhibitors

  • Source: Journal of cutaneous pathology [J Cutan Pathol] 2021 Mar; Vol. 48 (3), pp. 425-428. Date of Electronic Publication: 2020 Nov 15.Publisher: Wiley Country of Publication: United States NLM ID: 0425124 Publication Model: Print-Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Population pharmacokinetic model with time-varying clearance for lorlatinib using pooled data from patients with non-small cell lung cancer and healthy participants.

  • Authors : Chen J; Pfizer Oncology, New York, New York, USA.; Houk B

Subjects: Aminopyridines/Aminopyridines/Aminopyridines/*pharmacokinetics ; Anaplastic Lymphoma Kinase/Anaplastic Lymphoma Kinase/Anaplastic Lymphoma Kinase/*antagonists & inhibitors ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*drug therapy

  • Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Feb; Vol. 10 (2), pp. 148-160. Date of Electronic Publication: 2021 Feb 01.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Improving anticancer activity towards colon cancer cells with a new p53-activating agent.

  • Authors : Raimundo L; LAQV/REQUIMTE, Laboratório de Microbiologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.; Espadinha M

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*pharmacology ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy ; Lactams/Lactams/Lactams/*pharmacology

  • Source: British journal of pharmacology [Br J Pharmacol] 2018 Oct; Vol. 175 (20), pp. 3947-3962. Date of Electronic Publication: 2018 Sep 06.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants.

Subjects: Drug Interactions* ; Food-Drug Interactions*; Aminopyridines/Aminopyridines/Aminopyridines/*pharmacokinetics

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1395-1404. Date of Electronic Publication: 2021 Jul 20.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  875 results for ""LACTAMS""